Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy

Chronic gastritis: from histological protocol to substantiation of etiopathogenetic therapy

Gastritis is a reaction of the mucous membrane (MM) of the stomach to damage and is characterized by the formation of inflammatory, dystrophic and dysregenerative changes in the MM of the stomach, as well as atrophy of epithelial cells with replacement of normal glands with fibrous tissue. The progr...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. V. Dolgalev, E. N. Kareva, E. A. Lyalyukova, N. V. Pavlova
Format:	Article
Language:	Russian
Published:	Open Systems Publication 2021-06-01
Series:	Лечащий Врач
Subjects:	gastritis chronic gastritis h. pylori helicobacter pylori proton pump inhibitors
Online Access:	https://journal.lvrach.ru/jour/article/view/11
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medical budgeting at treatment sick Helicobacter-associations the chronic gastritis at stationary and out-patient-polyclinic stages
by: Ye. V. Sosnovskaya, et al.
Published: (2010-06-01)

Does bile reflux reduce Helicobacter pylori gastritis?
by: Ezgi Kıran Taşcı, et al.
Published: (2022-02-01)

Spectrum of Chronic Gastritis Based on Morphological Examination of Gastric Biopsies
by: А. S. Tertychnyy, et al.
Published: (2024-05-01)

The prevalence of atrophic gastritis of the body of stomach at Krasnoyarsk population over 45 years old
by: V. V. Tsukanov, et al.
Published: (2012-07-01)

Autoimmune Gastritis: Focus on Endoscopic and Morphological Characteristics
by: A. P. Kiryukhin, et al.
Published: (2024-03-01)

Russell Body Gastritis Disappeared after Helicobacter pylori Eradication
by: Key Jo Lee, et al.
Published: (2017-06-01)

Comparative genomic analysis of Helicobacter pylori isolates from gastric cancer and gastritis in China
by: Peng-fei Kong, et al.
Published: (2025-04-01)

Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01)

The Clinical Features and Helicobacter pylori Eradication Therapy in Lymphofollicular Gastritis: A Single Center Experience
by: Hong Ju An, et al.
Published: (2016-12-01)

Comparative study of gastric microbiota between patients with autoimmune gastritis and those with atrophic gastritis
by: Kengo Tokunaga, et al.
Published: (2025-07-01)

Association of Helicobacter pylori infection with nodular antritis and follicular gastritis
by: Tomašević Ratko, et al.
Published: (2006-01-01)

Validation of a Novel Endoscopic Feature that Predicts Helicobacter pylori-negative Status: Does the Scratch Sign Reflect H. pylori Non-infection?
by: Jun-young Seo, et al.
Published: (2023-09-01)

Comparative morphological characteristics of helicobacter pylori and autoimmune gastritis
by: N. V. Pachuashvili, et al.
Published: (2023-03-01)

Empathy, psychological characteristics, and compliance in patients with chronic gastritis
by: S. A. Smakotina, et al.
Published: (2022-06-01)

Relationship between Helicobacter Pylori Gastritis and Plasma Amino Acids
by: Derya Altay, et al.
Published: (2025-08-01)

Endoscopic Diagnosis of Early Gastric Cancer and High-Risk Gastritis
by: Hidekazu Suzuki, et al.
Published: (2024-12-01)

The efficacy of quadruple therapy in non-ulcer Helicobacter Pylory gastritis in children: A prospective study
by: Hien Thi Phan, et al.
Published: (2025-01-01)

Predictive Factors for Improvement of Atrophic Gastritis and Intestinal Metaplasia: A Long-term Prospective Clinical Study
by: Young-Jae Hwang, et al.
Published: (2018-09-01)

IMPACT OF CLINICAL AND IMMUNOLOGICAL PARAMETERS ON THE FREQUENCY AND PREVALENCE OF HELICOBACTER PYLORI IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Sh. F. Gadieva, et al.
Published: (2018-01-01)

Evaluation the relationship between the antibodies of Helicobacter pylori and Interleukin-6 in patients with gastritis in Kirkuk province
by: Allaa Qadir Muhammad, et al.
Published: (2023-01-01)

Clinical and Morphological Manifestations of Gastritis and Serum Cytokine Levels in Schoolchildren with Familial History of Gastric Cancer
by: T. V. Polivanova, et al.
Published: (2021-10-01)

Change in the Prevalences and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in Korea: Multicenter Clinical Trials
by: Young-Jae Hwang, et al.
Published: (2018-12-01)

Detection Rate of Helicobacter Pylori Infection and Atrophic Gastritis Using Serological Markers “GastroPanel®” Among Employees of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
by: A. D. Kaprin, et al.
Published: (2024-05-01)

Clinicopathological study of gastric biopsy in gastritis patients
by: Raveena Yallur, et al.
Published: (2024-10-01)

Dysplasia of stomach epithelium at chronic <i>H. pylori</i>-associated gastritis: is everything quite so simple?
by: T. L. Lapina, et al.
Published: (2015-07-01)

Evaluation of serum levels of Proinflammatory Cytokines IL-8, IL-17, and IL-22 in Helicobacter pylori infection and their association with the degree of gastritis histopathology in a sample of Iraqi patients
by: Miriam Jasim Shehab, et al.
Published: (2023-06-01)

The results of the effectiveness of pharmaceutical treatment of chronic gastritis with erosions associated with <i>Helicobacter pylori</i>with azithromycin and amoxicillin in the elderly
by: T. E. Afanasenkova, et al.
Published: (2024-04-01)

Relationship between Helicobacter pylori infection and gastroesophageal reflux disease
by: Seda Yılmaz, et al.
Published: (2024-12-01)

Analysis of Neutrophil, Leukocyte, Lymphocyte, and NLR Cell Profiles in Patients Diagnosed with Chronic Gastritis Affected by Helicobacter pylori and Non-Helicobacter pylori Infection at Dr. Soetomo Hospital in Surabaya, Indonesia
by: Nahdah Aulia Aziz, et al.
Published: (2025-01-01)

Pathogenetic Treatment of Gastritis as a Basis for the Prevention of Gastric Cancer in the Countries of the Commonwealth of Independent States: Literature Review and the Resolution of a Scientific Symposium Held in Minsk, Republic of Belarus, January, 27, 2018
by: V. T. Ivashkin, et al.
Published: (2018-09-01)

A Comparative Study of Immunohistochemical, Hematoxylin and Eosin, and Giemsa Stains for Demonstration of Helicobacter pylori in Cases of Chronic Antral Gastritis
by: Neeti Goyal, et al.
Published: (2025-05-01)

Multiple gastric tumors in patients with combined autoimmune and helicobacter pylori-associated gastritis: a case report and literature review
by: Wulian Lin, et al.
Published: (2025-05-01)

Helicobacteriosis and coronary heart disease: synthropic pathogenesis
by: O. N. Pavlov
Published: (2009-06-01)

Is It More Effective to Prescribe a Proton Pump Inhibitor Separately before a Meal for the Eradication of Helicobacter pylori?
by: Gyu Won Lee, et al.
Published: (2018-06-01)

Chinese phytopharmacology for gastritis - A systematic review of high-quality randomized controlled trials
by: Carla Cardiga, et al.
Published: (2025-06-01)

Comparative characteristics of cytokine regulation in patients with gastric diseases associated with <i>Helicobacter pylori</i> infection
by: O. V. Smirnova, et al.
Published: (2023-06-01)

Disruption of the biorhythm in gastric epithelial cell triggers inflammation in Helicobacter pylori-associated gastritis by aberrantly regulating NFIL3 via CagA activated ERK-SP1 pathway
by: Yongsheng Teng, et al.
Published: (2025-06-01)

Construction and validation of nomogram model for prognosis of gastritis patients based on baseline data and inflammatory and infectious markers
by: Lanfang Zhang, et al.
Published: (2025-07-01)

Regional features of management of patients diagnosed with chronic gastritis at the inpatient and outpatient-polyclinic stages. Brief pharmacoeconomic analysis
by: E. N. Chicherina, et al.
Published: (2021-06-01)

Functional Dyspepsia with Helicobacter pylori Infection
by: Rabbinu Rangga Pribadi, et al.
Published: (2017-08-01)